- Home
- NUS vs MGTX Comparison
NUS vs MGTX Comparison
Compare NUS & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NUS | MGTX |
|---|---|---|
| Founded | 1984 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 603.4M | 665.7M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | NUS | MGTX |
|---|---|---|
| Price | $9.84 | $7.97 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $7.00 | ★ $23.83 |
| AVG Volume (30 Days) | 435.6K | ★ 518.4K |
| Earning Date | 02-12-2026 | 11-13-2025 |
| Dividend Yield | ★ 2.44% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.20 | N/A |
| Revenue | ★ $1,560,391,000.00 | $27,417,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.12 | $619.95 |
| P/E Ratio | $4.47 | ★ N/A |
| Revenue Growth | N/A | ★ 96.83 |
| 52 Week Low | $5.32 | $4.55 |
| 52 Week High | $14.62 | $9.73 |
Technical Indicators
Market Signals| Indicator | NUS | MGTX |
|---|---|---|
| Relative Strength Index (RSI) | 43.37 | 45.34 |
| Support Level | $9.94 | $7.77 |
| Resistance Level | $10.35 | $8.40 |
| Average True Range (ATR) | 0.30 | 0.55 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 20.72 | 10.69 |
Price Performance
Historical ComparisonAbout NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.